Siying Wang

I joined the group of Rene Bernards at the NKI in February 2025 as a postdoctoral fellow.

My PhD work focused on the tumor suppressor gene, metabolism-involved carcinogenesis  and new cancer therapies. Building on this foundation, I aim to explore the drug-resistance mechanisms underlying existing cancer therapy, identify and translate new targets and new strategies for improving clinical benefits of cancer patients.